Mesa Laboratories MLAB
$ 133.48
1.58%
Quarterly report 2024-Q3
added 11-07-2024
Mesa Laboratories Balance Sheet 2011-2024 | MLAB
Annual Balance Sheet Mesa Laboratories
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
146 M | 140 M | 123 M | -118 M | 60 M | 12.6 M | 40.8 M | 49 M | 39.6 M | 24.2 M | 10.9 M | -6 K | -7.19 M | 2.95 M |
Long Term Debt |
171 M | 170 M | 169 M | 146 M | 140 M | 20.6 M | 44.6 M | 53.7 M | 42.2 M | 23.2 M | 16.5 M | 4 M | - | 1.5 M |
Long Term Debt Current |
2.99 M | 2.87 M | 2.77 M | - | - | 2.12 M | 1.62 M | 1.12 M | 3 M | 3 M | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 174 M | 21.8 M | 47.4 M | 57.3 M | 52.1 M | 29.2 M | 23 M | 8.5 M | 2.52 M | 4.64 M |
Total Current Liabilities |
44.3 M | 43.4 M | 48.1 M | 32.6 M | 26 M | 23.7 M | 17.3 M | 16.6 M | 24 M | 14.7 M | 10.2 M | 4.66 M | 4.26 M | - |
Total Liabilities |
301 M | 268 M | 314 M | 195 M | 200 M | 45.5 M | 64.7 M | 73.9 M | 76.1 M | 43.8 M | 33.2 M | 13.2 M | 6.78 M | 14.6 M |
Deferred Revenue |
15.5 M | 15.7 M | 13.8 M | 8.78 M | 6.81 M | 3.96 M | 3.92 M | 4.12 M | 3.03 M | 1.31 M | 1.89 M | - | - | - |
Retained Earnings |
-183 M | 74.2 M | 76.7 M | 72.5 M | 71.9 M | 73.3 M | 68.3 M | 73.7 M | 64.8 M | 56 M | 48.6 M | 42.2 M | 37.6 M | 31.3 M |
Total Assets |
447 M | 662 M | 707 M | 601 M | 420 M | 157 M | 164 M | 172 M | 161 M | 117 M | 97.5 M | 65.9 M | 50.7 M | 51 M |
Cash and Cash Equivalents |
28.2 M | 32.9 M | 49.3 M | 264 M | 81.4 M | 10.2 M | 5.47 M | 5.82 M | 5.7 M | 2.03 M | 5.58 M | 4.01 M | 7.19 M | 3.55 M |
Book Value |
145 M | 393 M | 394 M | 406 M | 220 M | 111 M | 99.4 M | 97.8 M | 84.7 M | 73.5 M | 64.3 M | 52.8 M | 43.9 M | 36.4 M |
Total Shareholders Equity |
145 M | 393 M | 394 M | 406 M | 220 M | 111 M | 99.4 M | 97.8 M | 84.7 M | 73.5 M | 64.3 M | 52.8 M | 43.9 M | 36.4 M |
All numbers in USD currency
Quarterly Balance Sheet Mesa Laboratories
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
73.1 M | 74.1 M | 171 M | 171 M | 171 M | 171 M | 170 M | 170 M | 170 M | - | 169 M | 169 M | 169 M | 169 M | 146 M | 144 M | 143 M | 142 M | 140 M | 139 M | 20.6 M | 17.5 M | 20.6 M | 27.2 M | 31.2 M | 37.7 M | 44.6 M | 54.6 M | 50.5 M | 49.3 M | 53.7 M | 50 M | 49.8 M | 43 M | 42.2 M | 44 M | 43.8 M | 22 M | 23.2 M | 25 M | 22.8 M | 25 M | 16.5 M | 16 M | - | 1.5 M | 4 M | 5 M | 8 M | 11 M | - | 750 K | - | - | 1.5 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
293 M | 290 M | 301 M | 339 M | 249 M | 255 M | 268 M | 276 M | 282 M | - | 314 M | 325 M | 210 M | 213 M | 195 M | 209 M | 197 M | 194 M | 189 M | 189 M | 163 M | 40.6 M | 45.5 M | 50.6 M | 53.4 M | 56 M | 64.7 M | 73.3 M | 68.7 M | 68 M | 73.9 M | 76.7 M | 76 M | 74.4 M | 76.1 M | 74.5 M | 76.9 M | 40.8 M | 43.8 M | 44.5 M | 42.5 M | 43.9 M | 33.2 M | 34 M | 9.22 M | 9.39 M | 13.2 M | 13.5 M | 16 M | 20.7 M | 6.78 M | 8.52 M | - | - | 14.1 M |
Deferred Revenue |
14.4 M | 14.6 M | 15.5 M | 14.4 M | 14.3 M | 15.4 M | 15.7 M | 14.6 M | 13.8 M | - | 13.8 M | 12.5 M | 9.74 M | 8.94 M | 8.78 M | 7.65 M | 6.79 M | 5.86 M | 6.81 M | 6.36 M | 3.98 M | 4.09 M | 3.96 M | 3.73 M | 3.74 M | 3.83 M | 3.92 M | 3.68 M | 3.8 M | 4.03 M | 4.12 M | 3.73 M | 3.38 M | 3.46 M | 3.03 M | 2.81 M | 3.04 M | 1.22 M | 1.31 M | 1.42 M | 1.26 M | 1.41 M | 1.89 M | 1.71 M | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-178 M | -181 M | -183 M | 72 M | 70.7 M | 72.8 M | 74.2 M | 74.4 M | 74.8 M | - | 76.7 M | 79.3 M | 82.2 M | 79.3 M | 72.5 M | 69.4 M | 74.7 M | 72.2 M | 72.4 M | 74.3 M | 79.6 M | 77.3 M | 73.3 M | 72.5 M | 72.3 M | 71.9 M | 68.3 M | 64.6 M | 76.3 M | 74.6 M | 73.7 M | 70.6 M | 67.9 M | 66.2 M | 64.8 M | 60.7 M | 58.9 M | 57.7 M | 56 M | 54.3 M | 52.4 M | 49.9 M | 48.6 M | 46.2 M | 45 M | 43.6 M | 41.6 M | 42.7 M | 41.2 M | 39.1 M | 35.7 M | 35.8 M | 34.1 M | 32.4 M | 31.3 M |
Total Assets |
454 M | 440 M | 447 M | 742 M | 637 M | 643 M | 662 M | 663 M | 656 M | - | 707 M | 722 M | 609 M | 612 M | 601 M | 622 M | 589 M | 577 M | 409 M | 423 M | 392 M | 160 M | 157 M | 158 M | 160 M | 161 M | 164 M | 168 M | 174 M | 169 M | 172 M | 170 M | 166 M | 162 M | 161 M | 155 M | 156 M | 117 M | 117 M | 116 M | 112 M | 110 M | 97.5 M | 92.6 M | 65.8 M | 63.8 M | 97.5 M | 63.6 M | 64.4 M | 66.7 M | 50.7 M | 50.2 M | 50.5 M | 52.2 M | 50.6 M |
Cash and Cash Equivalents |
24.3 M | 28.5 M | 28.2 M | 28.2 M | 35.6 M | 32.4 M | 32.9 M | 26.1 M | 32.4 M | - | 49.3 M | 51.7 M | 278 M | 276 M | 264 M | 254 M | 242 M | 231 M | 81.4 M | 74 M | 245 M | 7.32 M | 10.2 M | 5.73 M | 5.73 M | 5.62 M | 5.47 M | 5.84 M | 10.3 M | 2.98 M | 5.82 M | 5.4 M | 5.07 M | 4.64 M | 5.7 M | 3.27 M | 5.46 M | 1.97 M | 2.03 M | 1.43 M | 3.66 M | 3.2 M | 5.58 M | 2.16 M | 3.42 M | 3.59 M | 4.01 M | 2.72 M | 2.77 M | 4.59 M | 7.19 M | 5.69 M | 4.95 M | 6.05 M | 3.55 M |
Book Value |
161 M | 151 M | 145 M | 403 M | 388 M | 388 M | 393 M | 387 M | 374 M | - | 394 M | 396 M | 399 M | 399 M | 406 M | 413 M | 392 M | 382 M | 220 M | 234 M | 229 M | 119 M | 111 M | 108 M | 107 M | 105 M | 99.4 M | 94.4 M | 105 M | 101 M | 97.8 M | 93.7 M | 90.3 M | 87.7 M | 84.7 M | 80.6 M | 78.9 M | 76.4 M | 73.5 M | 71.7 M | 69.6 M | 66.4 M | 64.3 M | 58.5 M | 56.6 M | 54.5 M | 84.4 M | 50.1 M | 48.4 M | 46 M | 43.9 M | 41.7 M | 50.5 M | 52.2 M | 36.4 M |
Total Shareholders Equity |
161 M | 151 M | 145 M | 403 M | 388 M | 388 M | 393 M | 387 M | 374 M | 380 M | 394 M | 396 M | 399 M | 399 M | 399 M | 413 M | 392 M | 382 M | 220 M | 235 M | 234 M | 230 M | 119 M | 108 M | 108 M | 107 M | 99.4 M | 94.4 M | 105 M | 101 M | 97.8 M | 93.7 M | 90.3 M | 87.7 M | 84.7 M | 80.6 M | 78.9 M | 76.4 M | 73.5 M | 71.7 M | 69.6 M | 66.4 M | 64.3 M | 58.5 M | 56.6 M | 54.5 M | 52.8 M | 50.1 M | 48.4 M | 46 M | 43.9 M | 41.7 M | 40 M | 38.2 M | 36.4 M |
All numbers in USD currency